Gene sequencing company Illumina working towards cancer blood test

An American gene sequencing company is working towards a universal blood test to identify early-stage cancers in people with no symptoms of the disease. San Diego-based Illumina Inc. is forming a new company, called Grail, with more than AED 350 million of finance. Microsoft’s Bill Gates and Jeff Bezos, founder of are two of the high profile investors.

More from Business News